Kristin Muhlner

Affect Therapeutics, Inc.

Kristin serves as the CEO of Affect Therapeutics, the country's first addiction treatment provider to deliver an all-digital program that rewards healthy behaviors. Having led high-growth digital companies across both the enterprise and consumer sectors, she brings a deep yet diverse background to Affect, including CEO/senior executive roles at Sprinklr, Framebridge, newBrandAnalytics, and webMethods.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved